Navigation Links
NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
Date:3/19/2013

BETHESDA, Md., March 19, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Linda F. Powers , the Company's Chairman and Chief Executive Officer, will be presenting at the 25th Annual ROTH Conference at 8:30 a.m. PDT on Wednesday, March 20, 2013, at the Ritz-Carlton, Laguna Niguel, Dana Point, California.

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

Ms. Powers' presentation will discuss the Company's lead Phase III trial with DCVax-L for brain cancer, including guidance on enrollment, progress in Europe, and anticipated timelines for major milestones.  Ms. Powers will also discuss the Company's pending Phase I/II trial with DCVax-Direct for all solid tumor cancers that are inoperable, which is preparing to launch in Q2.  Ms. Powers will comment on the Company's key strengths and differentiation in the immune therapy space, and will announce certain new developments.

The presentation will take place in Track 8 of the conference, in The Promenade – White Room, and will be available by web cast at http://wsw.com/webcast/roth27/nwbo/.  The webcast will remain available for 90 days following the presentation.  It will also be available on the NW Bio Website starting on Thursday, March 21, 2013, at www.nwbio.com.

About Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more e
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
2. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
3. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
4. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
5. Nonprofit Consortium Publishes Review of Skullcap Adulteration
6. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
7. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
8. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials
9. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
10. Alzheimers Therapeutics Reviewed by NeuroPerspective
11. Peer Reviewed Clinical Study Shows New Blood Test More Accurately Predicts Risk Of A Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Crown Bioscience, Inc., a leading global ... new Life Science division specializing in in vivo and ... The first products released include in vivo grade human ... be released in vivo grade monoclonal antibodies against PD-L1 ... life science portfolio with additional antibody products as well ...
(Date:3/3/2015)... 2015 HubCast® Inc. ( http://www.hubcast.com ), ... the expansion of its Global Print Supply Chain with ... the world’s largest cities across 75 countries globally. ... countries providing global enterprises ease, speed, reach, quality, cost ... online order to real-world delivery at postal address around ...
(Date:3/3/2015)... , March 3, 2015 AtheroNova Inc. (OTCQB: AHRO) ... Inc., filed voluntary petitions under Chapter 11 of the U.S. ... California , Santa Ana ... Company,s Chapter 11 cases are expected to be jointly administered. ... Bankruptcy Court supervised asset sale process, for all or substantially ...
(Date:3/3/2015)... CAMBRIDGE, Mass. (PRWEB) March 03, 2015 ... driven by Semantic Web technology, today announced that it ... ‘100 Companies That Matter in Knowledge Management.’ , ... select group of colleagues, analysts and system integrators who ... and delivery of the right information to the right ...
Breaking Biology Technology:Crown Bioscience Launches Life Science Product Catalog 2HubCast Expands Global Print Supply Chain: Launches New Product Suite 2HubCast Expands Global Print Supply Chain: Launches New Product Suite 3HubCast Expands Global Print Supply Chain: Launches New Product Suite 4AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4Cambridge Semantics Named to KMWorld’s 2015 ‘100 Companies That Matter in Knowledge Management’ 2
... The Outercurve Foundation today announced the acceptance of ... Gallery. .Net Bio, a language-neutral, reusable .NET library ... for bioinformatics research, is the fourth project contributed ... has the support of bioinformatics researchers from a ...
... Oct. 18, 2011 Minimally Invasive Devices, Inc . ... product, FloShield PLUS , utilizing the novel Flo-X laparoscopic ... the end of the laparoscope without removal from the abdominal ... FloShield laparoscopic visualization system. In the first 19 FloShield PLUS ...
... Ikaria, Inc., a critical care company focused on developing ... needs of critically ill patients in the hospital and ... Daniel Tasse, will present at the 2011 Biotechnology Industry ... given on Tuesday, October 25, 2011 from 11:30 to ...
Cached Biology Technology:Outercurve Foundation Announces Contribution of .Net Bio Project 2Ikaria® to Present at 2011 BIO Investor Forum 2
(Date:2/19/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ... "Military Electro-Optical / Infrared Systems Market by Type, ... Forecast to 2020" report to their offering. ... is expected to reach $16.35 billion by 2020, ... This report segments the military electro-optical/infrared systems market ...
(Date:2/11/2015)... 11, 2015 According ... Control Market by Product (Cards and Readers, Biometrics, Controllers, ... Government, Industrial, Healthcare, Education) and By Geography - Global Forecast and ... the Access Control Market is expected to ... a CAGR of 10.6% between 2014 and ...
(Date:2/5/2015)... --  Epic Sciences , a precision diagnostics company dedicated to ... Prahalad , Ph.D., president and CEO, is scheduled to present ... Silicon Valley, which is taking place at the Computer History ... January 26-28, 2015. Dr. Prahalad will give ... year, Epic Sciences was a finalist in the PMWC,s Most ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... corks to celebrate New Year,s Eve, drug industry executives will ... pharmaceutical companies who make top-selling drugs for heart disease, asthma, ... midst of mounting market pressures and a global recession. A ... is scheduled for the current issue of Chemical & ...
... paper published this week in the journal Proceedings of ... the structure and function of a key player in regulating ... UBC assistant professor of medical genetics and a scientist at ... & Family Research Institute. Chromatin, a dynamic DNA-protein complex, ...
... Mich. Ground-breaking discoveries by Michigan State University researchers ... devastated commercial colonies. The MSU researchers for the ... proteins that help channel sodium ions through cell membranes ... cellular frog eggs, also found that these proteins react ...
Cached Biology News:MSU research may lead to new ways to control honeybee parasite 2
golgi reassembly stacking protein 2, 55kDa...
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
activating transcription factor 4 (tax-responsive enhancer element B67),...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Biology Products: